Value of tissue elastography in the prediction of efficacy of neoadjuvant chemotherapy in breast cancer

被引:5
|
作者
Fang, Chao [1 ]
Wu, Tingting [1 ]
Zhou, Yingying [1 ]
Xue, Jun [1 ]
Yang, Weiwei [1 ]
机构
[1] Zhabei Cent Hosp, 619 Zhonghua Xin Rd, Shanghai 200043, Peoples R China
来源
JOURNAL OF BUON | 2019年 / 24卷 / 02期
关键词
breast cancer; neoadjuvant chemotherapy; real-time tissue elastography; strain ratio; ULTRASOUND ELASTOGRAPHY; PATHOLOGICAL RESPONSE; SHEAR-WAVE; SYSTEM;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of the present study was to explore the value of real-time tissue elastography (RTE) in predicting the efficacy of neoadjuvant chemotherapy (NAC) in breast cancer. Methods: A total of 60 patients with breast cancer who received NAC in our hospital were evaluated. According to the pathological results, 47 patients were included in the significant response group and 13 patients in the non-significant response group. The maximum diameter and strain ratio (B/A ratio) of lesions before and 1st, 2nd, 4th and 6th week after NAC were recorded and compared. The receiver operation characteristics (ROC) curve of the lesion diameter and strain rate ratio (B/A value) were used to predict the value of NAC efficacy. Results: The lesions in the two groups showed a honeycomb-like reduction after NAC. The blue color in the elastic image gradually decreased, and the green color gradually increased. Repeated analyses of variance (ANOVA) found that the maximum diameter and B/A value showed a downward trend within 6 weeks of NAC treatment. The maximum diameter and B/A value in the significant response group were significantly lower than the non-significant response group before and after the NAC. There was an interaction in the maximum diameter and B/A value between the significant response group and the non-significant response group. The above differences were statistically significant (all p <0.05). The area under the curve (AUC) of Delta B/A value at 2nd week of NAC was maximal (0.944), and the best diagnostic point was 5.64. The sensitivity was 92.31% and the specificity 87.23%. Conclusions: Delta B/A value at 2nd week of NAC is helpful in predicting the therapeutic effect of NAC in breast cancer.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 50 条
  • [1] The value of shear-wave elastography for prediction of treatment response to neoadjuvant chemotherapy in patients with breast cancer
    Bae, Soong June
    Kim, Min Ji
    Cha, Yoon Jin
    Eun, Na Lae
    Kim, Dooreh
    Lee, Janghee
    Ahn, Sung Gwe
    Son, Eon Ju
    Jeong, Joon
    CANCER RESEARCH, 2021, 81 (04)
  • [2] The Value of Ultrasonic Elastography Combined With Serum ATF5 in Predicting the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer
    Wang, Xiang-dong
    Jiang, Wei
    Wu, Wei
    Liu, Yi-ni
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E509 - E511
  • [3] Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer
    Kim, Kwanil
    Lee, Kyunghee
    Park, Heungkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
    Wang, Huan
    Mao, Xiaoyun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2423 - 2433
  • [5] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Maria, G.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S95 - S95
  • [6] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    BREAST, 2017, 32 : S79 - S79
  • [7] PREDICTION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN BREAST CANCER
    Myllys, Maiju
    EXCLI JOURNAL, 2021, 20 : 625 - 627
  • [8] Prediction of neoadjuvant chemotherapy efficacy in breast cancer: integrating multimodal imaging and clinical features
    Xianglong Chen
    Yong Luo
    Zhiming Xie
    Yun Wen
    Fangsheng Mou
    Wenbing Zeng
    BMC Medical Imaging, 25 (1)
  • [9] Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    Fuksa, L.
    Micuda, S.
    Grim, J.
    Ryska, A.
    Hornychova, H.
    CANCER INVESTIGATION, 2012, 30 (09) : 663 - 678
  • [10] Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI
    Liu, Yongguang
    Wu, Mingxiang
    Tan, Wenyong
    Gong, Jingshan
    Ma, Jie
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022